EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Current Advances in Liver-Targeted Drug Delivery: Synthetic, Biological, and Biomimetic Platforms

Shynggys Sergazy iD, Roza B Seidakhmetova, Yernur Zakirov iD, Askhat Zhilkaidarov iD, Damirzhan Amirbek, Zarina Shulgau iD, Kulzhan Berikkhanova iD, Alexandr Gulyaev

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27177959 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Shynggys Sergazy und 7 weiteren Autor:innen. Beteiligte Einrichtung: LLP VICTUS PHARM, Astana 010000, Kazakhstan. Hauptthemen laut MEDLINE: Liver, Drug Delivery Systems, Biomimetics, Biomimetic Materials. Die Arbeit nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Republic of Kazakhstan, Nazarbayev University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver-targeted drug delivery offers opportunities to increase therapeutic exposure at sites of hepatic disease while limiting systemic toxicity; however, successful targeting requires more than preferential accumulation of a carrier within the liver. This narrative review critically summarizes recent advances in synthetic, biological, and biomimetic delivery platforms, including lipid, polymeric, inorganic, and protein-based nanoparticles, nucleic acid nanocarriers, extracellular vesicles, plant-derived nanovesicles, cell-mediated systems, and cell membrane-coated nanoparticles. A literature search was conducted using PubMed, Web of Science, and Embase, with emphasis on studies published during the last decade and updated through 24 August 2026. Particular attention is given to the biological determinants of hepatic biodistribution, including sinusoidal architecture, physicochemical carrier properties, protein corona formation, receptor–ligand interactions, and disease-associated alterations in the hepatic microenvironment. The review distinguishes organ-level hepatic accumulation from cell-specific uptake and productive intracellular delivery and discusses strategies directed toward hepatocytes, hepatic stellate cells, Kupffer cells and other macrophages, liver sinusoidal endothelial cells, neutrophils, and additional immune-cell populations. Major delivery platforms are critically compared with respect to the evidence supporting targeting specificity, cargo compatibility, administration route, reported safety and immunogenicity, manufacturability, analytical characterization, and translational maturity. Particular consideration is given to extracellular vesicle- and plant-derived nanovesicle-based approaches, for which biological activity, biodistribution, standardization, and scalability remain important areas of investigation. Overall, current research in liver-targeted delivery is increasingly focused on moving beyond nonspecific organ accumulation toward disease-adapted, cell-specific, and intracellularly productive delivery, although substantial biological, manufacturing, and regulatory challenges remain before many emerging approaches can achieve routine clinical translation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiverDrug Delivery SystemsBiomimeticsBiomimetic MaterialsLiver DiseasesHumansAnimalsNanoparticlesDrug CarriersTissue Distribution

Stichwörter der Autor:innen

biomimetic drug deliverycell-mediated deliverycell-specific targetingextracellular vesicleshepatic stellate cellshepatocytesliver-targeted drug deliverynanocarriersnanoparticlesplant-derived nanovesicles

Substanzen

Drug Carriers

Autor:innen und Institutionen

  • LLP VICTUS PHARM, Astana 010000, Kazakhstan.
  • Private Institution "National Laboratory Astana", Nazarbayev University, Astana 010000, Kazakhstan.
  • University Medical Center, Nazarbayev University, Astana 010000, Kazakhstan.
  • Professor G.V. Tsoi Scientific and Educational Center of Surgery, Astana Medical University, Astana 010000, Kazakhstan.

ORCID-Profile: Shynggys Sergazy, Yernur Zakirov, Askhat Zhilkaidarov, Zarina Shulgau, Kulzhan Berikkhanova

Förderung

  • Ministry of Science and Higher Education of the Republic of Kazakhstan
  • Nazarbayev University

Zitieren

APA

Sergazy, S., Seidakhmetova, R. B., Zakirov, Y., Zhilkaidarov, A., Amirbek, D., Shulgau, Z., Berikkhanova, K., & Gulyaev, A. (2026). Current Advances in Liver-Targeted Drug Delivery: Synthetic, Biological, and Biomimetic Platforms. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27177959

Vancouver

Sergazy S, Seidakhmetova RB, Zakirov Y, Zhilkaidarov A, Amirbek D, Shulgau Z, et al. Current Advances in Liver-Targeted Drug Delivery: Synthetic, Biological, and Biomimetic Platforms. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27177959

BibTeX
@article{Sergazy2026,
  author = {Sergazy, Shynggys and Seidakhmetova, Roza B and Zakirov, Yernur and Zhilkaidarov, Askhat and Amirbek, Damirzhan and Shulgau, Zarina and Berikkhanova, Kulzhan and Gulyaev, Alexandr},
  title = {Current Advances in Liver-Targeted Drug Delivery: Synthetic, Biological, and Biomimetic Platforms},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27177959}
}
Kostenlos starten →